What we're reading, December 1, 2015: $1 alternative to Daraprim being made available; over-the-counter medications are convenient and affordable but have their own dangers; and an analysis looks at the reasons why prescription drugs are so much more expensive in the US.
Express Scripts Will Sell $1 Daraprim Alternative
Following Turing Pharmaceuticals’ controversial decision to increase the price of the 62-year-old Daraprim to $750 a pill from $13.50 a pill, Express Scripts and Imprimis Pharmaceuticals will partner to increase access to a low-cost alternative of the drug. Daraprim is used to treat toxoplasmosis and the price increase puts it out of reach for people with HIV, pregnant women, and others with weakened immune systems. The compounded alternative will only cost $1 per capsule.
The Dangers of Over-the-Counter Medications
Over-the-counter medications used commonly to treat a variety of ailments are convenient and affordable, but are often used inappropriately. The New York Times reported that one-fifth of American adults admit to taking more than the recommended dose and using over-the-counter medications more frequently than they should. In addition, few consult a doctor or pharmacists first.
Behind the Higher Cost of Prescription Drugs in America
Although the cost of living in Norway is higher than the US, the price of prescription drugs is far higher in America, according to an analysis from The Wall Street Journal. Comparing drug prices paid for by Medicare Part B with those paid by Norway’s taxpayer-funded health system, the analysis revealed that 93% of 40 top branded drugs were more expensive in the US. The Journal found similar results when comparing the US to England and Canada’s Ontario province.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More